Belgium: Disclosure of Transfers of Values
The disclosure of transfers of values to Healthcare Professionals (HCP) and Healthcare Organisation (HCO) is part of the transparency initiative developed by the European Federation of Pharmaceutical Industries and Associations and PHARMA.BE.
Servier adheres and fully supports the objectives promoted through this self-regulatory initiative.
Pharmaceutical companies have to interact with the medical community in order to advance scientific knowledge and improve patient care. These interactions regularly imply important work/time/involvement from HCP and HCO, like for example the setting and follow up of clinical trials. The outcome of this publication will contribute to provide a better insight on our interactions.
PHARMA.BE proposes additional information on the publication principles followed by pharmaceutical companies locally.
For Belgium, the publication of Servier’s transfers of values is available here
This publication has been prepared in accordance with the requirements of Sunshine Act, more particularly chapter 1 of title 3 of the Law of 18 December 2016 regarding various provisions on health, Belgian official Journal 27 December 2016. The interactions listed in this document include all transfers of values made from 1st January to 31st December by all companies of the Servier Group, locally or from foreign countries.